Bigr Ventures
BIGR Ventures is a growth equity fund based in Boulder, Colorado, founded in 2015 by Carole Buyers, Bill Weiland, and Duane Primozich. The firm specializes in natural and organic products, leveraging over 70 years of combined industry experience. The team is known for its deep industry relationships and strategic partnerships, which help maximize the potential of early-stage companies.
BIGR Ventures focuses on sectors such as food and agriculture, consumer goods, and health. They typically invest in Seed to Series B stages, with check sizes ranging from $500K to $3M. The firm primarily invests in the United States and has a strong presence in the natural products sector. Notable funds include their growth equity fund, which supports promising young companies in these industries.
Notable investments by BIGR Ventures include Fat Snax - healthy snacks, RE Botanicals - organic hemp products, Soozy’s Grain-Free - gluten-free treats, Hope Foods - organic hummus, Bonafide Provisions - organic bone broth, REBBL - super herb elixirs, and Bobo’s Oat Bars - oat-based snacks.
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is a philanthropic organization based in Seattle, Washington. It was established by Bill and Melinda Gates in 2000 and is known for its focus on addressing global health and education inequities. With a diverse team that spans across the globe, it emphasizes collaboration with partners to solve pressing issues, and is especially known for its scientific and health-based approach to philanthropy.
The foundation primarily invests in sectors such as global health, education, agricultural development, and economic empowerment. It works in regions including Africa, India, and parts of Asia, focusing on initiatives related to infectious diseases, child and maternal health, and climate adaptation. While its exact total AUM is not clearly stated, the foundation directs significant funds towards sustaining impactful change in line with its mission.
Some of the notable programs and initiatives supported by the foundation include the Malaria program, efforts in maternal and child health, Agricultural Development initiatives, and the Digital Public Infrastructure. These programs aim to create lasting health improvements and opportunities for economic advancement in the communities they serve.
Bin Hamoodah Group
Binhamoodah.com is an investment firm whose specific focus, team composition, or background details are currently unavailable due to an underdeveloped website. The firm's home city, founding year, or founding team is also not publicly shared at this time, making it difficult to ascertain what distinguishes them from other investment firms.
The firm's website does not provide any specific information about sector focus, preferred investment sizes, stages of investments, geographic focus, total assets under management, or strategic partners. Without such details, it remains unclear what areas or domains the firm prioritizes in its investment activities.
Likewise, the firm has not listed any notable portfolio companies, leaving their track record and history of investments difficult to assess. Overall, until more comprehensive information is made available or the website is updated, insights into the firm's investment strategy and specific projects will remain limited.
Binary Capital
Binary Capital is an early-stage venture capital firm based in San Francisco, California, established in 2014 by Jonathan Teo. The firm is led by a team with deep expertise in the technology sector, supporting entrepreneurs innovating on consumer products and alternative infrastructure. Jonathan Teo, a serial entrepreneur and Stanford graduate, founded the firm after gaining extensive experience at Google, Benchmark Capital, and General Catalyst. With a focus on technological advancement and innovation, Binary Capital brings a unique insight into the early-stage venture capital landscape.
Binary Capital invests across multiple sectors in the technology space, with a particular emphasis on consumer technology and infrastructure. The firm has a significant presence in key geographies such as Singapore and London. Its investment size varies from $1-5 million, indicative of its early-stage investment focus. While specific fund details are not disclosed, the firm has generated returns exceeding $2.3 billion USD for its investors.
Notable investments by Binary Capital include companies that have become industry-defining giants such as Snapchat, Instagram, Twitter, Toss (Viva Republica), Patreon, SpaceX, and Bitfury. These portfolio companies highlight Binary's impact on the global tech scene through early-stage engagement with innovative enterprises that focus on consumer technology and infrastructure.
BinDawood Holdings
BinDawood Holding (Listed at Saudi Exchange in 2020 under the ticker of 4161), a retail conglomerate that focuses on information technology and retail solutions, it capitalizes on investment opportunities, driving long-term growth. Driven by a vision for sustained growth, BinDawood Holding continues to solidify its position as a frontrunner in the retail industry, poised to capitalize on emerging opportunities and deliver exceptional value to stakeholders. BinDawood Holding continues to shape the retail landscape through constant innovation and a steadfast commitment to excellence by operating its business under the brands of BinDawood, Danube, BinDawood Dash, Danube Dash, IACo, and Ykone.
Brands of BinDawood Holding Company:
- BinDawood: One of Saudi Arabia’s leading grocery retail brands, BinDawood operates 25 hypermarkets, supermarkets, and express stores across the country. Known for excellent value and outstanding customer service, it has become an iconic brand in the Kingdom.
- Danube: A high-end grocery retailer, Danube is celebrated for its quality and freshness, offering a diverse selection of organic and specialty products. It is one of Saudi Arabia's most esteemed brands in the grocery sector.
- BinDawood Dash and Danube Dash: These brands introduced the express store concept at the Haramain High-Speed Railway Station, featuring premium quality imported goods, providing convenience for busy travelers.
- Ykone: A global influencer marketing leader headquartered in Paris, Ykone offers comprehensive solutions in strategy, talent management, content production, and monitoring for leading brands worldwide.
- IACo: Manages BinDawood Holding’s e-commerce channels and is expanding dark stores throughout Saudi Arabia to ensure prompt delivery and high customer satisfaction. It also provides digital support services and implements a loyalty program, enhancing data-driven decision-making and customer engagement.
Binomial Ventures
We are looking for early and medium stage companies in Europe and North America with disruptive business models in fintech, cybersecurity and AI. We focus on developing partner relationship with founders and are ready to help them pursue their dreams.
BioCrossroads
BioCrossroads is a venture capital firm based in Indianapolis, Indiana, founded in 2002. The firm focuses on catalyzing growth in Indiana's life sciences sector by fostering collaboration among research institutions, global companies, and government bodies. With a small team of professionals, BioCrossroads is dedicated to advancing innovation and investment in the life sciences industry, particularly in biotechnology, pharmaceuticals, and medical devices.
The firm invests in startups and entrepreneurs within the life sciences domain, providing a supportive ecosystem that includes mentorship and funding. BioCrossroads primarily targets sectors such as biotechnology, pharmaceuticals, medical devices, and health information technology. While specific check sizes are not disclosed, the firm is actively seeking new investments and is a member of the National Venture Capital Association.
Notable investments by BioCrossroads include companies like Gate Neurosciences, MBX Biosciences, and Scioto Biosciences. These investments highlight the firm's commitment to supporting innovative companies in drug discovery, healthcare services, and biotechnology. BioCrossroads also engages with the community through events like the annual Life Sciences Summit, which focuses on advancements in AI applications for life sciences.
Bioeconomy Capital
Bioeconomy Capital (BeC) invests in early stage companies with the goal of accelerating the biotechnology revolution. Based on our startup operational expertise, product development experience, and globally recognized strategic analysis, we have developed a blueprint for building and deploying technological capabilities that will become critical infrastructure of the 21st century economy. This proprietary blueprint is the distillation of the fund managers' five decades of combined experience in synthetic biology and other engineering fields and cannot be readily duplicated. Prior investments include Zymergen, Riffyn, Synthace, RoosterBio, Arzeda, Bellwether Bio, EdenWorks, and Lumen Biosciences
BioGeneration Ventures
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.
BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit.
Historical successful investments include divestment of Dezima Pharma to Amgen for up to USD 1.55 billion in total deal value and in Acerta Pharma for up to USD 7 billion with a guaranteed payment of USD 4 billion. Both companies were co-founded by BGV in 2012 and 2013 respectively. The Acerta Pharma sale was the largest exit ever of a privately held European biotech company.
BGV is based in Naarden, The Netherlands, and closely collaborates with Forbion.
Bioprocess Capital Ventures
The limited liability company Management Company Bioprocess Capital Partners was established on October 6, 2006 to manage the funds of Russian venture company (RVC). Bioprocess Capital Ventures focused on biomedical and fine chemistry startups.